Literature DB >> 2788200

An infant rat model of bacteremia with Brazilian purpuric fever isolates of Hemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group.

L G Rubin1, E S Gloster, G M Carlone.   

Abstract

Brazilian purpuric fever (BPF) is a newly recognized fulminant pediatric infection caused by bacteremia with Hemophilus influenzae biogroup aegyptius (Hae). Following intraperitoneal inoculation, each of five disease isolates caused bacteremia more frequently than control, conjunctival isolates of Hae in complement-depleted 6-d-old rats. Sustained but self-limited bacteremia was observed in normal infant rats after inoculation with a disease strain. These rats developed meningitis and had depressed hemoglobin concentration and platelet counts. Pathologic examination showed meningitis and contiguous otitis. Pretreatment of infant rats with immune adult rat serum raised against disease isolates protected rats from bacteremia. Normal adult rat serum or immune rat serum against control strains failed to protect infant rats. Thus, strains of Hae isolated from patients with BPF are more virulent than control strains. Antibody against antigens unique to disease isolates protects infant rats from bacteremia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788200     DOI: 10.1093/infdis/160.3.476

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Duplication of pilus gene complexes of Haemophilus influenzae biogroup aegyptius.

Authors:  T D Read; M Dowdell; S W Satola; M M Farley
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

Review 2.  Emergence and disappearance of a virulent clone of Haemophilus influenzae biogroup aegyptius, cause of Brazilian purpuric fever.

Authors:  Lee H Harrison; Vera Simonsen; Eliseu A Waldman
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

3.  Antibodies to lipooligosaccharide of a Brazilian purpuric fever isolate of Haemophilus influenzae biogroup aegyptius lack bactericidal and protective activity.

Authors:  V B Peters; L G Rubin
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

Authors:  R B Reed; J B Frost; K Kort; S D Myers; A J Lesse
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Role of the 145-kilodalton surface protein in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats.

Authors:  L G Rubin
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Antibody to a 145-kilodalton outer membrane protein has bactericidal activity and protective activity against experimental bacteremia caused by a Brazilian purpuric fever isolate of Haemophilus influenzae biogroup aegyptius. The Brazilian Purpuric Fever Study Group.

Authors:  L G Rubin; A Rizvi
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

7.  Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats.

Authors:  L G Rubin; J W St Geme
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever.

Authors:  F D Quinn; R S Weyant; M J Worley; E H White; E A Utt; E A Ades
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Lineage-specific virulence determinants of Haemophilus influenzae biogroup aegyptius.

Authors:  Fiona R Strouts; Peter Power; Nicholas J Croucher; Nicola Corton; Andries van Tonder; Michael A Quail; Paul R Langford; Michael J Hudson; Julian Parkhill; J Simon Kroll; Stephen D Bentley
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.